# HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness

> **NCT05280028** · — · RECRUITING · sponsor: **Far Eastern Memorial Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Menopausal Syndrome

## Interventions

- **DRUG:** Tibolone 2.5 mg
- **DRUG:** Estradiol valerate 1 mg/medroxyprogesterone acetate 2.5 mg

## Key facts

- **NCT ID:** NCT05280028
- **Lead sponsor:** Far Eastern Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-07
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05280028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05280028, "HRT on Overactive Bladder Symptoms, Sexual Function, Depressive Symptoms, Autonomic Function, and Arterial Stiffness". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05280028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*